3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Annals of Oncology
          Annals of Oncology
          Elsevier BV
          09237534
          September 2022
          September 2022
          : 33
          : S1390-S1391
          Article
          10.1016/j.annonc.2022.08.019
          565bac07-7dbc-4a46-baf5-65e041150218
          © 2022

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article